Show simple item record

dc.contributor.authorLemmer, Hendrik J.R.
dc.contributor.authorHamman, Josias H.
dc.date.accessioned2015-05-21T10:20:03Z
dc.date.available2015-05-21T10:20:03Z
dc.date.issued2013
dc.identifier.citationLemmer, H.J.R. & Hamman, J.H. 2013. Paracellular drug absorption enhancement through tight junction modulation. Expert opinion on drug delivery, 10(1):103-114. [https://doi.org/10.1517/17425247.2013.745509]en_US
dc.identifier.issn1742-5247
dc.identifier.issn1744-7593 (Online)
dc.identifier.urihttp://hdl.handle.net/10394/13849
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.1517/17425247.2013.745509
dc.identifier.urihttps://doi.org/10.1517/17425247.2013.745509
dc.description.abstractIntroduction: Inclusion of absorption-enhancing agents in dosage forms is one approach to improve the bioavailability of active pharmaceutical ingredients with low membrane permeability. Tight junctions are dynamic protein structures that form a regulated barrier for movement of molecules through the intercellular spaces across the intestinal epithelium. Some drug absorption enhancers are capable of loosening tight junctions and thereby facilitate paracellular absorption of drug molecules. Areas covered: The physiology of tight junctions as well as the mechanisms through which tight junctions can be modulated is discussed. Selected tight junction modulators are specifically described including chelating agents (e.g., ethylenediaminetetraacetic acid), cationic polymers (e.g., chitosan and derivatives), toxins (e.g., zonula occludens toxin), and plant-derived materials (e.g., Aloe vera gel). Expert opinion: As more and more drugs are developed with low membrane permeability, new interest is generated in finding ways to enhance their absorption. The progress made in comprehending the function and structure of tight junctions has contributed to advances in terms of enhanced drug delivery through the paracellular pathway. Although tight junction modulation holds great potential for effective oral delivery of poorly absorbable drugs, many challenges still need to be overcome before more clinically successful formulations could be produced Read More: http://informahealthcare.com/doi/abs/10.1517/17425247.2013.745509en_US
dc.language.isoenen_US
dc.publisherTaylor & Francisen_US
dc.subjectAbsorption enhancementen_US
dc.subjectChitosanen_US
dc.subjectParacellular pathwayen_US
dc.subjectTight junctionen_US
dc.subjectZonula occludens toxinen_US
dc.titleParacellular drug absorption enhancement through tight junction modulationen_US
dc.typeArticleen_US
dc.contributor.researchID10081097 - Hamman, Josias Hendrik
dc.contributor.researchID12932574 - Lemmer, Hendrik Jacobus Righard


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record